Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of preoperative vs postoperative letrozole in postmenopausal women with operable hormone receptor-positive breast cancer
2008-005067-33Phase 3Terminated
- Sponsor
- Danish Breast Cancer Cooperative Group
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole in breast cancer (2 arms), sponsored by Danish Breast Cancer Cooperative Group. Primary endpoint: Invasive disease-free survival. Started Dec 2008; status: terminated.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-005067-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005067-33.